These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9541693)

  • 1. Detection of chromosome 3p alterations in serum DNA of non-small-cell lung cancer patients.
    Sánchez-Céspedes M; Monzó M; Rosell R; Pifarré A; Calvo R; López-Cabrerizo MP; Astudillo J
    Ann Oncol; 1998 Jan; 9(1):113-6. PubMed ID: 9541693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of microsatellite alterations in the DNA isolated from tumor cells and from plasma DNA of patients with lung cancer.
    Bruhn N; Beinert T; Oehm C; Jandrig B; Petersen I; Chen XQ; Possinger K; Fleischhacker M
    Ann N Y Acad Sci; 2000 Apr; 906():72-82. PubMed ID: 10818600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting lung cancer in plasma with the use of multiple genetic markers.
    Andriani F; Conte D; Mastrangelo T; Leon M; Ratcliffe C; Roz L; Pelosi G; Goldstraw P; Sozzi G; Pastorino U
    Int J Cancer; 2004 Jan; 108(1):91-6. PubMed ID: 14618621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of replication errors on chromosomes 2p and 3p in non-small-cell lung cancer.
    Pifarré A; Rosell R; Monzó M; De Anta JM; Moreno I; Sánchez JJ; Ariza A; Mate JL; Martińez E; Sánchez M
    Br J Cancer; 1997; 75(2):184-9. PubMed ID: 9010024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of exhaled microsatellite alterations at 3p in NSCLC patients.
    Carpagnano GE; Spanevello A; Carpagnano F; Palladino GP; Prato R; Martinelli D; Digioia G; Foschino-Barbaro MP
    Lung Cancer; 2009 Jun; 64(3):334-40. PubMed ID: 18995925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No evidence of microsatellite instability but frequent loss of heterozygosity in primary resected lung cancer.
    Pylkkänen L; Karjalainen A; Anttila S; Vainio H; Husgafvel-Pursiainen K
    Environ Mol Mutagen; 1997; 30(2):217-23. PubMed ID: 9329646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite instability and loss of heterozygosity at chromosomes 9 and 17 in non-small cell lung cancer.
    Froudarakis ME; Sourvinos G; Fournel P; Bouros D; Vergnon JM; Spandidos DA; Siafakas NM
    Chest; 1998 Apr; 113(4):1091-4. PubMed ID: 9554652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.
    Bearzatto A; Conte D; Frattini M; Zaffaroni N; Andriani F; Balestra D; Tavecchio L; Daidone MG; Sozzi G
    Clin Cancer Res; 2002 Dec; 8(12):3782-7. PubMed ID: 12473590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients: a prospect for early diagnosis.
    Sozzi G; Musso K; Ratcliffe C; Goldstraw P; Pierotti MA; Pastorino U
    Clin Cancer Res; 1999 Oct; 5(10):2689-92. PubMed ID: 10537330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsatellite alteration at chromosome 3p loci in neuroendocrine and non-neuroendocrine lung tumors. Histogenetic and clinical relevance.
    Hurr K; Kemp B; Silver SA; el-Naggar AK
    Am J Pathol; 1996 Aug; 149(2):613-20. PubMed ID: 8701999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsatellite alterations at 5q21, 11p13, and 11p15.5 do not predict survival in non-small cell lung cancer.
    Sánchez-Céspedes M; Rosell R; Pifarré A; López-Cabrerizo MP; Barnadas A; Sánchez JJ; Lorenzo JC; Abad A; Monzó M; Navas-Palacios JJ
    Clin Cancer Res; 1997 Jul; 3(7):1229-35. PubMed ID: 9815804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.
    Ludovini V; Pistola L; Gregorc V; Floriani I; Rulli E; Piattoni S; Di Carlo L; Semeraro A; Darwish S; Tofanetti FR; Stocchi L; Mihaylova Z; Bellezza G; Del Sordo R; Daddi G; Crinò L; Tonato M
    J Thorac Oncol; 2008 Apr; 3(4):365-73. PubMed ID: 18379354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers.
    Kishimoto Y; Sugio K; Hung JY; Virmani AK; McIntire DD; Minna JD; Gazdar AF
    J Natl Cancer Inst; 1995 Aug; 87(16):1224-9. PubMed ID: 7563168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-free circulating tumor DNA in plasma/serum of non-small cell lung cancer.
    Nie K; Jia Y; Zhang X
    Tumour Biol; 2015 Jan; 36(1):7-19. PubMed ID: 25352029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Distinguishing second primary tumors from lung metastasis in patients with postoperative non-small cell lung cancer by microsatellite analysis].
    Wang J; Lu C; Liu XY; Zhang HB; Zhao J; Yang L; Guo QZ; An TT; Wu MN
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Feb; 30(2):103-7. PubMed ID: 17445470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implication of microsatellite alteration profiles in early-stage non-small cell lung cancer.
    Zhou X; Kemp BL; Khuri FR; Liu D; Lee JJ; Wu W; Hong WK; Mao L
    Clin Cancer Res; 2000 Feb; 6(2):559-65. PubMed ID: 10690539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity at 3p in non-small cell lung cancer and its prognostic implication.
    Mitsudomi T; Oyama T; Nishida K; Ogami A; Osaki T; Sugio K; Yasumoto K; Sugimachi K; Gazdar AF
    Clin Cancer Res; 1996 Jul; 2(7):1185-9. PubMed ID: 9816286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic alterations in bronchial mucosa and plasma DNA from individuals at high risk of lung cancer.
    Allan JM; Hardie LJ; Briggs JA; Davidson LA; Watson JP; Pearson SB; Muers MF; Wild CP
    Int J Cancer; 2001 Feb; 91(3):359-65. PubMed ID: 11169960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies of microsatellite instability and loss of heterozygosity at chromosome 17 in non-small cell lung carcinoma].
    Guo X; Ni P; Li L
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Dec; 22(12):743-5. PubMed ID: 11776784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
    Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
    Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.